Close Menu

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

The trial will be the first AML study to use next-generation sequencing to determine MRD-negative complete response rates as a primary endpoint.

The firm is hoping to identify new signals of activity for its lead compound in combination with other agents across a variety of solid and hematologic cancers.

The company's lead candidate lacutamab is moving into the second part of a Phase II trial for biomarker-defined cutaneous T-cell lymphoma patients.

Pfizer is the first drugmaker to join the Strata PATH platform trial and will contribute drugs to advanced cancer patients in four study arms.

Phio will finance the clinical trial slated to start this year and be entitled to future development milestone and sales-based payments from AgonOx.

Sponsored by

This webinar will discuss a single-center prospective interventional study that evaluated the success of a targeted therapy selected by profiling of ctDNA and tissue in patients with advanced and refractory carcinoma.